Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological research using RNA interference technology.

Chih-Ping Mao1, Yen-Yu Lin, Chien-Fu Hung

  • 1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimire, MD 21231, USA.

Immunology
|April 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathological characterization of cervical squamous cell carcinoma with <i>PIK3CA</i> hotspot mutation: A single-institution study.

Oncology letters·2026
Same author

Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancer.

The Journal of clinical investigation·2026
Same author

A mouse model of HPV-associated cervicovaginal carcinosarcoma with comparative analysis to human clinical cases.

Cell & bioscience·2026
Same author

Crypt Dysplasia is a Risk Factor for the Development of High-Grade Dysplasia/Adenocarcinoma in Barrett Esophagus.

The American journal of surgical pathology·2026
Same author

Personalizing DNA Cancer Vaccines.

Journal of personalized medicine·2025
Same author

Comparative Analysis Reveals Recurrent Molecular Alterations in Low-Risk Human Papillomavirus 6 and Human Papillomavirus 11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same journal

Epidermal Dominance of Metabolically Constrained Immune Niches Underpins Immune Activation Signatures and Clinical Severity in Psoriatic Disease.

Immunology·2026
Same journal

Thymic APC Networks Orchestrate T-Cell Selection: Mechanisms and Therapeutic Opportunities in Immune Disorders.

Immunology·2026
Same journal

Immune Checkpoints in Leukaemia as Gatekeepers of Immuno-Modulation.

Immunology·2026
Same journal

Senescent Human Liver Endothelial Cells Mediate CD4<sup>+</sup> T Cell Recruitment via ICOSL.

Immunology·2026
Same journal

The Transcription Factor EGR2 Plays a Central Role in the Expansion and Function of TCRαβ<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> Double Negative T Cells in lpr Lupus Mice.

Immunology·2026
Same journal

Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.

Immunology·2026
See all related articles

RNA interference (RNAi) is a powerful gene silencing tool with applications in immunology and potential clinical use. Overcoming delivery and specificity challenges is key to its future in vaccination and immunotherapy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • RNA interference (RNAi) is a significant gene silencing method.
  • RNAi provides insights into immune system regulation.
  • RNAi holds potential for modulating immune responses.

Purpose of the Study:

  • Review current immunological research using RNAi.
  • Discuss the clinical implementation prospects of RNAi.
  • Highlight advancements and challenges in RNAi technology.

Main Methods:

  • Literature review of RNAi applications in immunology.
  • Analysis of RNAi's role in cellular immunity.
  • Examination of RNAi's potential in clinical settings.

Main Results:

Related Experiment Videos

  • RNAi elucidates immune cell development and function.
  • RNAi demonstrates potential for regulating immune responses.
  • Current limitations include delivery, gene silencing efficiency, and off-target effects.

Conclusions:

  • RNAi is a promising tool for in vivo gene silencing.
  • Further development is needed to overcome limitations for clinical use.
  • RNAi is expected to impact vaccination and immunotherapy significantly.